Literature DB >> 23413374

Safety of epicenter versus intact parenchyma as a transplantation site for human neural stem cells for spinal cord injury therapy.

Katja M Piltti1, Desirée L Salazar, Nobuko Uchida, Brian J Cummings, Aileen J Anderson.   

Abstract

Neural stem cell transplantation may have the potential to yield repair and recovery of function in central nervous system injury and disease, including spinal cord injury (SCI). Multiple pathological processes are initiated at the epicenter of a traumatic spinal cord injury; these are generally thought to make the epicenter a particularly hostile microenvironment. Conversely, the injury epicenter is an appealing potential site of therapeutic human central nervous system-derived neural stem cell (hCNS-SCns) transplantation because of both its surgical accessibility and the avoidance of spared spinal cord tissue. In this study, we compared hCNS-SCns transplantation into the SCI epicenter (EPI) versus intact rostral/caudal (R/C) parenchyma in contusion-injured athymic nude rats, and assessed the cell survival, differentiation, and migration. Regardless of transplantation site, hCNS-SCns survived and proliferated; however, the total number of hCNS-SCns quantified in the R/C transplant animals was twice that in the EPI animals, demonstrating increased overall engraftment. Migration and fate profile were unaffected by transplantation site. However, although transplantation site did not alter the proportion of human astrocytes, EPI transplantation shifted the localization of these cells and exhibited a correlation with calcitonin gene-related peptide fiber sprouting. Critically, no changes in mechanical allodynia or thermal hyperalgesia were observed. Taken together, these data suggest that the intact parenchyma may be a more favorable transplantation site than the injury epicenter in the subacute period post-SCI.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23413374      PMCID: PMC3659765          DOI: 10.5966/sctm.2012-0110

Source DB:  PubMed          Journal:  Stem Cells Transl Med        ISSN: 2157-6564            Impact factor:   6.940


  48 in total

1.  Direct isolation of human central nervous system stem cells.

Authors:  N Uchida; D W Buck; D He; M J Reitsma; M Masek; T V Phan; A S Tsukamoto; F H Gage; I L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

2.  Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery.

Authors:  C P Hofstetter; E J Schwarz; D Hess; J Widenfalk; A El Manira; Darwin J Prockop; L Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

3.  Pluripotent stem cells engrafted into the normal or lesioned adult rat spinal cord are restricted to a glial lineage.

Authors:  Q L Cao; Y P Zhang; R M Howard; W M Walters; P Tsoulfas; S R Whittemore
Journal:  Exp Neurol       Date:  2001-01       Impact factor: 5.330

4.  Pain and dysesthesia in patients with spinal cord injury: A postal survey.

Authors:  N B Finnerup; I L Johannesen; S H Sindrup; F W Bach; T S Jensen
Journal:  Spinal Cord       Date:  2001-05       Impact factor: 2.772

5.  Embryonic stem cells differentiate into oligodendrocytes and myelinate in culture and after spinal cord transplantation.

Authors:  S Liu; Y Qu; T J Stewart; M J Howard; S Chakrabortty; T F Holekamp; J W McDonald
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

Review 6.  The athymic nude rat: an animal experimental model to reveal novel aspects of innate immune responses?

Authors:  B Rolstad
Journal:  Immunol Rev       Date:  2001-12       Impact factor: 12.988

7.  Human neural stem cells induce functional myelination in mice with severe dysmyelination.

Authors:  Nobuko Uchida; Kevin Chen; Monika Dohse; Kelly D Hansen; Justin Dean; Joshua R Buser; Art Riddle; Douglas J Beardsley; Ying Wan; Xi Gong; Thuan Nguyen; Brian J Cummings; Aileen J Anderson; Stanley J Tamaki; Ann Tsukamoto; Irving L Weissman; Steven G Matsumoto; Larry S Sherman; Christopher D Kroenke; Stephen A Back
Journal:  Sci Transl Med       Date:  2012-10-10       Impact factor: 17.956

8.  Neurophysiological assessment of the feasibility and safety of neural tissue transplantation in patients with syringomyelia.

Authors:  F J Thompson; P J Reier; B Uthman; S Mott; R G Fessler; A Behrman; M Trimble; D K Anderson; E D Wirth
Journal:  J Neurotrauma       Date:  2001-09       Impact factor: 5.269

9.  Characterization and intraspinal grafting of EGF/bFGF-dependent neurospheres derived from embryonic rat spinal cord.

Authors:  S Y Chow; J Moul; C A Tobias; B T Himes; Y Liu; M Obrocka; L Hodge; A Tessler; I Fischer
Journal:  Brain Res       Date:  2000-08-25       Impact factor: 3.252

Review 10.  Experimental modelling of human spinal cord injury: a model that crosses the species barrier and mimics the spectrum of human cytopathology.

Authors:  B T Stokes; L B Jakeman
Journal:  Spinal Cord       Date:  2002-03       Impact factor: 2.772

View more
  21 in total

1.  Transplantation dose alters the dynamics of human neural stem cell engraftment, proliferation and migration after spinal cord injury.

Authors:  Katja M Piltti; Sabrina N Avakian; Gabriella M Funes; Antoinette Hu; Nobuko Uchida; Aileen J Anderson; Brian J Cummings
Journal:  Stem Cell Res       Date:  2015-07-26       Impact factor: 2.020

2.  Spinal Progenitor-Laden Bridges Support Earlier Axon Regeneration Following Spinal Cord Injury.

Authors:  Courtney M Dumont; Mary K Munsell; Mitchell A Carlson; Brian J Cummings; Aileen J Anderson; Lonnie D Shea
Journal:  Tissue Eng Part A       Date:  2018-10-19       Impact factor: 3.845

3.  Injectable polypeptide hydrogels via methionine modification for neural stem cell delivery.

Authors:  A L Wollenberg; T M O'Shea; J H Kim; A Czechanski; L G Reinholdt; M V Sofroniew; T J Deming
Journal:  Biomaterials       Date:  2018-04-05       Impact factor: 12.479

Review 4.  Cell transplantation therapy for spinal cord injury.

Authors:  Peggy Assinck; Greg J Duncan; Brett J Hilton; Jason R Plemel; Wolfram Tetzlaff
Journal:  Nat Neurosci       Date:  2017-04-25       Impact factor: 24.884

5.  Achieving Informed Consent for Cellular Therapies: A Preclinical Translational Research Perspective on Regulations versus a Dose of Reality.

Authors:  Aileen J Anderson; Brian J Cummings
Journal:  J Law Med Ethics       Date:  2016-09       Impact factor: 1.718

6.  Human induced pluripotent stem cells are a novel source of neural progenitor cells (iNPCs) that migrate and integrate in the rodent spinal cord.

Authors:  Dhruv Sareen; Geneviève Gowing; Anais Sahabian; Kevin Staggenborg; Renée Paradis; Pablo Avalos; Jessica Latter; Loren Ornelas; Leslie Garcia; Clive N Svendsen
Journal:  J Comp Neurol       Date:  2014-04-12       Impact factor: 3.215

Review 7.  Mechanism of Neuroprotection Against Experimental Spinal Cord Injury by Riluzole or Methylprednisolone.

Authors:  Cynthia Sámano; Andrea Nistri
Journal:  Neurochem Res       Date:  2017-12-30       Impact factor: 3.996

8.  Safety of human neural stem cell transplantation in chronic spinal cord injury.

Authors:  Katja M Piltti; Desiree L Salazar; Nobuko Uchida; Brian J Cummings; Aileen J Anderson
Journal:  Stem Cells Transl Med       Date:  2013-11-04       Impact factor: 6.940

9.  Immunosuppressants affect human neural stem cells in vitro but not in an in vivo model of spinal cord injury.

Authors:  Christopher J Sontag; Hal X Nguyen; Noriko Kamei; Nobuko Uchida; Aileen J Anderson; Brian J Cummings
Journal:  Stem Cells Transl Med       Date:  2013-08-27       Impact factor: 6.940

10.  Neural precursor cell transplantation enhances functional recovery and reduces astrogliosis in bilateral compressive/contusive cervical spinal cord injury.

Authors:  Jared T Wilcox; Kajana Satkunendrarajah; Jeffrey A Zuccato; Farshad Nassiri; Michael G Fehlings
Journal:  Stem Cells Transl Med       Date:  2014-08-08       Impact factor: 6.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.